Chi Xiangyang, Yu Changming, Chen Wei
Beijing Institute of Biotechnology, Beijing 100071, China.
Sheng Wu Gong Cheng Xue Bao. 2012 Jun;28(6):651-60.
Monoclonal antibodies (mAbs) contribute a lot to the development of numerous fields in life science as a pivotal tool in modern biological research. Development of the PCR methods and maturation of antibody production have made it possible to generate mAbs from single human B cells by single cell RT-PCR with successional cloning and expression in vitro. Compared to traditional monoclonal antibody technologies, single B cell technologies require relatively fewer cells, which are highly efficient in obtaining specific mAbs in a rapid way with preservation of the natural heavy and light chain pairing. With so many advantages, single B cell technologies have been proved to be an attractive approach for retrieval of naive and antigen-experienced antibody repertoires generated in vivo, design of rationale structure-based vaccine, evaluation and development of basic B cell biology concepts in health and autoimmunity, and prevention of infectious diseases by passive immunization and therapy for disorders. Accordingly, this review introduced recent progresses in the single B cell technologies for generating monoclonal antibodies and applications.
单克隆抗体(mAbs)作为现代生物学研究中的关键工具,对生命科学众多领域的发展贡献巨大。PCR方法的发展和抗体生产技术的成熟,使得通过单细胞RT-PCR从单个人类B细胞中生成mAbs,并在体外进行连续克隆和表达成为可能。与传统单克隆抗体技术相比,单B细胞技术所需细胞相对较少,能够高效快速地获得特异性mAbs,并保留天然重链和轻链配对。单B细胞技术具有诸多优势,已被证明是一种有吸引力的方法,可用于检索体内产生的天然和抗原经验性抗体库、基于合理结构的疫苗设计、健康和自身免疫中基础B细胞生物学概念的评估和发展,以及通过被动免疫预防传染病和治疗疾病。因此,本综述介绍了用于生成单克隆抗体的单B细胞技术及其应用的最新进展。